Profile data is unavailable for this security.
About the company
Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.
- Revenue in USD (TTM)3.26bn
- Net income in USD-692.75m
- Incorporated2017
- Employees10.70k
- LocationAdapthealth Corp220 W Germantown Pike Ste 250PLYMOUTH MEETING 19462United StatesUSA
- Phone+1 (610) 630-6357
- Fax+1 (302) 636-5454
- Websitehttps://adapthealth.com/investor-relations/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Artivion Inc | 376.97m | -8.32m | 1.05bn | 1.50k | -- | 3.56 | 70.16 | 2.79 | -0.2076 | -0.2076 | 9.11 | 7.06 | 0.481 | 1.67 | 5.44 | 251,316.00 | -1.07 | -2.20 | -1.15 | -2.36 | 64.63 | 65.51 | -2.22 | -5.34 | 4.04 | 1.07 | 0.5177 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Avanos Medical Inc | 682.40m | 7.00m | 1.13bn | 3.77k | 161.12 | 0.9277 | 21.73 | 1.66 | 0.1532 | 0.1671 | 14.71 | 26.62 | 0.4105 | 1.93 | 5.20 | 180,960.00 | 0.4211 | -0.6527 | 0.4737 | -0.7338 | 55.82 | 54.45 | 1.03 | -1.60 | 1.49 | 7.06 | 0.1253 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Pulse Biosciences Inc | 0.00 | -44.02m | 1.15bn | 56.00 | -- | 38.36 | -- | -- | -0.7916 | -0.7916 | 0.00 | 0.4883 | 0.00 | -- | -- | 0.00 | -76.43 | -93.21 | -84.97 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| BioLife Solutions Inc | 121.17m | -53.87m | 1.19bn | 409.00 | -- | 3.69 | -- | 9.79 | -1.21 | -1.64 | 2.69 | 6.97 | 0.2999 | 1.99 | 5.39 | 296,254.30 | -13.33 | -13.76 | -14.60 | -15.04 | 41.27 | 36.76 | -44.46 | -42.99 | 1.81 | -5.98 | 0.0651 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Establishment Labs Holdings Inc | 151.35m | -83.20m | 1.23bn | 857.00 | -- | 27.28 | -- | 8.12 | -3.11 | -3.11 | 5.62 | 1.61 | 0.5307 | 0.8525 | 2.72 | 166,685.00 | -29.17 | -33.22 | -34.29 | -41.12 | 66.04 | 64.73 | -54.97 | -43.19 | 2.91 | -20.68 | 0.8114 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| Owens & Minor, Inc. | 10.53bn | -42.44m | 1.24bn | 13.70k | -- | 1.44 | 5.15 | 0.1174 | -0.5532 | -0.5532 | 137.98 | 11.17 | 1.99 | 6.95 | 15.78 | 768,728.30 | -0.8014 | 1.32 | -1.25 | 2.07 | 20.78 | 16.48 | -0.403 | 0.5614 | 0.5141 | 2.11 | 0.7076 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Inmode Ltd | 416.63m | 149.20m | 1.35bn | 581.00 | 10.24 | 1.95 | 9.03 | 3.25 | 1.73 | 1.73 | 4.84 | 9.09 | 0.5228 | 1.62 | 11.78 | 717,084.30 | 18.72 | 31.32 | 20.79 | 35.64 | 82.27 | 84.46 | 35.81 | 39.65 | 8.09 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| Integra Lifesciences Holdings Corp | 1.57bn | 23.65m | 1.36bn | 3.95k | 59.00 | 0.8834 | 8.89 | 0.8652 | 0.2961 | 0.2961 | 20.02 | 19.77 | 0.399 | 1.55 | 5.81 | 396,986.10 | 0.6023 | 3.33 | 0.6618 | 3.68 | 61.54 | 63.67 | 1.51 | 7.99 | 2.10 | 5.88 | 0.5433 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| AtriCure Inc | 429.95m | -40.12m | 1.40bn | 1.20k | -- | 3.04 | -- | 3.26 | -0.8606 | -0.8606 | 9.22 | 9.49 | 0.7217 | 1.68 | 8.27 | 358,294.20 | -6.73 | -3.72 | -7.58 | -4.10 | 74.84 | 74.36 | -9.33 | -7.64 | 2.93 | -11.79 | 0.12 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Adapthealth Corp | 3.26bn | -692.75m | 1.52bn | 10.70k | -- | 1.01 | -- | 0.466 | -5.17 | -5.17 | 24.29 | 11.14 | 0.6714 | 22.22 | 8.12 | 304,741.80 | -14.15 | -4.34 | -15.89 | -4.89 | 18.63 | 18.28 | -21.07 | -6.47 | 0.9438 | 2.17 | 0.5866 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| STAAR Surgical Co | 332.94m | 16.61m | 1.55bn | 1.06k | 94.33 | 3.80 | 70.38 | 4.67 | 0.335 | 0.335 | 6.75 | 8.32 | 0.6984 | 2.13 | 3.54 | 315,286.00 | 3.49 | 6.77 | 3.99 | 7.90 | 79.24 | 76.89 | 4.99 | 9.16 | 5.21 | -- | 0.0003 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Warby Parker Inc | 719.93m | -45.90m | 1.77bn | 2.14k | -- | 5.36 | -- | 2.45 | -0.387 | -0.387 | 6.05 | 2.75 | 1.22 | 5.68 | 603.46 | 336,415.40 | -7.78 | -- | -9.68 | -- | 55.37 | 57.49 | -6.38 | -14.53 | 2.11 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| Novocure Ltd | 549.96m | -168.70m | 1.93bn | 1.45k | -- | 5.33 | -- | 3.51 | -1.58 | -1.58 | 5.13 | 3.35 | 0.4639 | 3.62 | 8.11 | 378,502.40 | -14.23 | -7.74 | -16.44 | -8.95 | 75.83 | 77.22 | -30.67 | -14.69 | 6.22 | -- | 0.6437 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
| Patterson Companies, Inc. | 6.53bn | 168.41m | 1.96bn | 7.60k | 12.16 | 2.06 | 7.61 | 0.3003 | 1.83 | 1.83 | 71.22 | 10.80 | 2.27 | 5.86 | 15.35 | 859,640.70 | 5.84 | 1.13 | 10.15 | 1.81 | 21.03 | 20.98 | 2.57 | 0.5157 | 0.6723 | 7.91 | 0.4474 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
| Omnicell Inc | 1.08bn | -20.76m | 2.00bn | 3.65k | -- | 1.66 | 30.90 | 1.85 | -0.4558 | -0.4558 | 23.63 | 26.15 | 0.4818 | 5.64 | 4.20 | 296,013.40 | -0.9258 | 1.73 | -1.12 | 2.25 | 41.63 | 46.69 | -1.92 | 2.92 | 2.22 | -- | 0.322 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
Data as of Sep 19 2024. Currency figures normalised to Adapthealth Corp's reporting currency: US Dollar USD
37.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2024 | 12.42m | 9.24% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 10.41m | 7.74% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 6.60m | 4.91% |
| Reinhart Partners, Inc.as of 30 Jun 2024 | 4.27m | 3.18% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 3.44m | 2.56% |
| Segall Bryant & Hamill LLCas of 30 Jun 2024 | 3.21m | 2.38% |
| Truist Bank (Private Banking)as of 30 Jun 2024 | 3.06m | 2.28% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 2.19m | 1.63% |
| Geode Capital Management LLCas of 30 Jun 2024 | 2.19m | 1.63% |
| Palisade Capital Management LPas of 30 Jun 2024 | 2.17m | 1.61% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
